Abstract:Abstract Objective To develop a prediction model for relapse risk in medication overuse headache (MOH) based on resting-state electroencephalographic (EEG) brain network features. Methods Baseline resting-state EEG data and clinical information were collected from patients with MOH, followed by long-term follow-up. Source-space functional connectivity networks were constructed using the phase-locking value (PLV). Based on graph theory analysis, differences in the sumstrength within the occipital network and salience network across different frequency bands were compared. Logistic regression models were then established. Results A total of 211 patients with MOH were enrolled. 195 patients were included in the final analysis after preprocessing. 172 patients completed the first-month follow-up after treatment and 108 patients showed effective treatment response. 52 patients had a follow-up duration of at least 1 year, including 9 who were lost to follow-up, 10 who relapsed, and 33 who did not relapse. In addition, 9 patients relapsed within less than 1 year of follow-up. Therefore, 19 patients were included in the relapse group and 33 in the non-relapse group. At baseline, headache history, headache frequency and analgesic use frequency were all significantly higher in the relapse group than in the non-relapse group. EEG analysis showed that the sumstrength within the visual network in the relapse group was decreased in the delta band but increased in the theta band, whereas no statistically significant differences were observed in the salience network across frequency bands. The model based on the sumstrength within the visual network in the theta band achieved an area under the curve (AUC) of 0.997(95% CI: 0.989?1) for predicting relapse and demonstrated good calibration and clinical net benefit. Conclusion The sumstrength within the occipital network in the theta band may serve as a potential objective neuroelectrophysiological biomarker for predicting relapse in MOH patients.